CENTESSA PHARMACEUTICALS PLC Increase (Decrease) in Accounts Payable
CENTESSA PHARMACEUTICALS PLC reported Increase (Decrease) in Accounts Payable of $3.26 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-05-05
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $3.26M.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.31M, a 1017.48% decline year-over-year.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $3.28M, a 92.26% increase year-over-year.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for the quarter ending 2025-06-30 was $177.00K.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for fiscal 2025 was $50.00K.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for fiscal 2024 was -$4.58M.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for fiscal 2023 was -$2.72M, a 142.86% decline from fiscal 2022.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accounts payable for fiscal 2022 was $6.35M.
| Period end | Increase (Decrease) in Accounts Payable 1 month | Increase (Decrease) in Accounts Payable 2 month | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 5 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 11 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.26M 10-Q · filed 2026-05-05 | $1.95M derived: sum of 2 quarters · filed 2026-05-05 | $5.23M derived: sum of 3 quarters · filed 2026-05-05 | $5.41M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.97M derived: sum of 2 quarters · filed 2026-03-31 | $2.15M derived: sum of 3 quarters · filed 2026-03-31 | $50.00K 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.46M derived: sum of 2 quarters · filed 2025-11-05 | $1.36M 10-Q · filed 2025-11-05 | $1.50M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-06-30 | $177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.92M 10-Q · filed 2025-08-12 | -$1.77M derived: sum of 3 quarters · filed 2026-05-05 | -$69.00K derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-03-31 | -$2.10M 10-Q · filed 2026-05-05 | -$1.95M derived: sum of 2 quarters · filed 2026-05-05 | -$246.00K derived: sum of 3 quarters · filed 2026-05-05 | -$2.43M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2024-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.85M derived: sum of 2 quarters · filed 2026-03-31 | -$335.00K derived: sum of 3 quarters · filed 2026-03-31 | -$4.58M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$478.00K derived: sum of 2 quarters · filed 2025-11-05 | -$4.73M 10-Q · filed 2025-11-05 | -$4.14M derived: sum of 4 quarters · filed 2025-11-05 | |||||
| 2024-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$6.43M 10-Q · filed 2025-08-12 | -$5.85M derived: sum of 3 quarters · filed 2025-08-12 | -$5.76M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | -$4.25M 10-Q · filed 2025-05-14 | -$3.66M derived: sum of 2 quarters · filed 2025-05-14 | -$3.58M derived: sum of 3 quarters · filed 2025-05-14 | -$5.16M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $669.00K derived: sum of 2 quarters · filed 2025-03-24 | -$907.00K derived: sum of 3 quarters · filed 2025-03-24 | -$2.72M 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.49M derived: sum of 2 quarters · filed 2024-11-12 | -$3.31M 10-Q · filed 2024-11-12 | -$712.00K derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$3.39M 10-Q · filed 2024-08-13 | -$795.00K derived: sum of 3 quarters · filed 2024-08-13 | $2.34M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | -$1.81M 10-Q · filed 2024-05-13 | $781.00K derived: sum of 2 quarters · filed 2024-05-13 | $3.91M derived: sum of 3 quarters · filed 2024-05-13 | $5.76M derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.73M derived: sum of 2 quarters · filed 2024-03-28 | $7.57M derived: sum of 3 quarters · filed 2024-03-28 | $6.35M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.97M derived: sum of 2 quarters · filed 2023-11-13 | $3.75M 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $623.00K 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | -$1.22M 10-Q · filed 2023-05-12 | ||||||||
| 2021-12-31 | $4.16M 10-K · filed 2023-03-30 | ||||||||
| 2021-09-30 | $5.53M 10-Q · filed 2022-11-10 | ||||||||
| 2021-06-30 | $2.16M 10-Q · filed 2022-08-10 | ||||||||
| 2021-03-31 | $6.55M 10-Q · filed 2022-05-16 | ||||||||
| 2021-01-29 | -$358.00K 10-K · filed 2023-03-30 | ||||||||
| 2020-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $384.00K derived: sum of 2 quarters · filed 2022-03-30 | -$49.00K 10-K · filed 2022-03-30 | ||||||
| 2020-09-30 | $391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$42.00K 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | -$433.00K 10-Q · filed 2021-08-16 | ||||||||
| 2019-12-31 | $855.00K 10-K · filed 2022-03-30 |